TY - JOUR
T1 - Use of drugs, perceived drug efficacy and preferred providers for febrile children
T2 - Implications for home management of fever
AU - Rutebemberwa, Elizeus
AU - Nsabagasani, Xavier
AU - Pariyo, George
AU - Tomson, Goran
AU - Peterson, Stefan
AU - Kallander, Karin
N1 - Funding Information:
This study received financial support from Sida/SAREC – Makerere University – Karolinska Institutet research collaboration and from UNICEF/ UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases. Its contents are solely the responsibility of the authors and do not reflect the views of Sida/SAREC nor UNICEF/UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases nor the authors' institutions of affiliation. The study participants, research assistants, Iganga/Mayuge Demographic Surveillance Site, Iganga and Mayuge districts, WHO/Uganda and Ministry of Health Uganda are all acknowledged for their support and contribution.
PY - 2009
Y1 - 2009
N2 - Background. Community distribution of anti-malarials and antibiotics has been recommended as a strategy to reduce the under-five mortality due to febrile illnesses in sub-Saharan Africa. However, drugs distributed in these interventions have been considered weak by some caretakers and utilization of community medicine distributors has been low. The aim of the study was to explore caretakers' use of drugs, perceptions of drug efficacy and preferred providers for febrile children in order to make suggestions for community management of pneumonia and malaria. Methods. The study was conducted in eastern Uganda using four focus group discussions with fathers and mothers of children under five; and eight key informant interviews with health workers in government and non-governmental organization facilities, community medicine distributors, and attendants in drug shops and private clinics. Caretakers were asked the drugs they use for treatment of fever, why they considered them efficacious, and the providers they go to and why they go there. Health providers were interviewed on their opinions of caretakers' perceptions of drugs and providers. Analysis was done using content analysis. Results. Drugs that have been phased out as first-line treatment for malaria, such as chloroquine and sulphadoxine/pyrimethamine, are still perceived as efficacious. Use of drugs depended on perception of the disease, cost and drug availability. There were divergent views about drug efficacy concerning drug combinations, side effects, packaging, or using drugs over time. Bitter taste and high cost signified high efficacy for anti-malarials. Government facilities were preferred for conducting diagnostic investigations and attending to serious illnesses, but often lacked drugs and did not treat people fast. Drug shops were preferred for having a variety of drugs, attending to clients promptly and offering treatment on credit. However, drug shops were considered disadvantageous since they lacked diagnostic capability and had unqualified providers. Conclusion. Community views about drug efficacy are divergent and some may divert caretakers from obtaining efficacious drugs for febrile illness. Interventions should address these perceptions, equip community medicine distributors with capacity to do diagnostic investigations and provide a constant supply of drugs. Subsidized efficacious drugs could be made available in the private sector.
AB - Background. Community distribution of anti-malarials and antibiotics has been recommended as a strategy to reduce the under-five mortality due to febrile illnesses in sub-Saharan Africa. However, drugs distributed in these interventions have been considered weak by some caretakers and utilization of community medicine distributors has been low. The aim of the study was to explore caretakers' use of drugs, perceptions of drug efficacy and preferred providers for febrile children in order to make suggestions for community management of pneumonia and malaria. Methods. The study was conducted in eastern Uganda using four focus group discussions with fathers and mothers of children under five; and eight key informant interviews with health workers in government and non-governmental organization facilities, community medicine distributors, and attendants in drug shops and private clinics. Caretakers were asked the drugs they use for treatment of fever, why they considered them efficacious, and the providers they go to and why they go there. Health providers were interviewed on their opinions of caretakers' perceptions of drugs and providers. Analysis was done using content analysis. Results. Drugs that have been phased out as first-line treatment for malaria, such as chloroquine and sulphadoxine/pyrimethamine, are still perceived as efficacious. Use of drugs depended on perception of the disease, cost and drug availability. There were divergent views about drug efficacy concerning drug combinations, side effects, packaging, or using drugs over time. Bitter taste and high cost signified high efficacy for anti-malarials. Government facilities were preferred for conducting diagnostic investigations and attending to serious illnesses, but often lacked drugs and did not treat people fast. Drug shops were preferred for having a variety of drugs, attending to clients promptly and offering treatment on credit. However, drug shops were considered disadvantageous since they lacked diagnostic capability and had unqualified providers. Conclusion. Community views about drug efficacy are divergent and some may divert caretakers from obtaining efficacious drugs for febrile illness. Interventions should address these perceptions, equip community medicine distributors with capacity to do diagnostic investigations and provide a constant supply of drugs. Subsidized efficacious drugs could be made available in the private sector.
UR - http://www.scopus.com/inward/record.url?scp=67949109665&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67949109665&partnerID=8YFLogxK
U2 - 10.1186/1475-2875-8-131
DO - 10.1186/1475-2875-8-131
M3 - Article
C2 - 19523220
AN - SCOPUS:67949109665
SN - 1475-2875
VL - 8
JO - Malaria Journal
JF - Malaria Journal
IS - 1
M1 - 131
ER -